DK0591280T3 - Anvendelse af tetrahydrocarbazolderivater som 5HT1-receptoragonister - Google Patents

Anvendelse af tetrahydrocarbazolderivater som 5HT1-receptoragonister

Info

Publication number: DK0591280T3
Authority: DK; Denmark
Prior art keywords: receptor agonists; tetrahydrocarbazole derivatives; tetrahydrocarbazole; derivatives; agonists
Prior art date: 1991-06-26

Application number

DK92912379T

Other languages

Danish (da)

English (en)

Inventor

Francis David King

Laramie Mary Gaster

Alberto Julio Kaumann

Rodney Christopher Young

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-06-26

Filing date

1992-06-17

Publication date

1999-02-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10697363&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0591280(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1992-06-17 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

1999-02-15 Application granted granted Critical

1999-02-15 Publication of DK0591280T3 publication Critical patent/DK0591280T3/da

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Pain & Pain Management (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK92912379T 1991-06-26 1992-06-17 Anvendelse af tetrahydrocarbazolderivater som 5HT1-receptoragonister DK0591280T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB919113802A GB9113802D0 (en)	1991-06-26	1991-06-26	Medicaments
PCT/GB1992/001082 WO1993000086A1 (en)	1991-06-26	1992-06-17	Use of tetrahydrocarbazone derivatives as 5ht1 receptor agonists

Publications (1)

Publication Number	Publication Date
DK0591280T3 true DK0591280T3 (da)	1999-02-15

Family

ID=10697363

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK92912379T DK0591280T3 (da)	1991-06-26	1992-06-17	Anvendelse af tetrahydrocarbazolderivater som 5HT1-receptoragonister

Country Status (35)

Country	Link
US (2)	US5464864A (cs)
EP (1)	EP0591280B1 (cs)
JP (1)	JP3261502B2 (cs)
KR (1)	KR100251571B1 (cs)
CN (1)	CN1034072C (cs)
AP (1)	AP344A (cs)
AT (1)	ATE170746T1 (cs)
BR (2)	BR9206237A (cs)
CA (1)	CA2113726C (cs)
CZ (3)	CZ282083B6 (cs)
DE (2)	DE69226953T2 (cs)
DK (1)	DK0591280T3 (cs)
FI (1)	FI103967B1 (cs)
GB (1)	GB9113802D0 (cs)
HK (1)	HK1014669A1 (cs)
HU (1)	HU218907B (cs)
IE (1)	IE922062A1 (cs)
IL (4)	IL117105A (cs)
LU (1)	LU90939I2 (cs)
MA (1)	MA22563A1 (cs)
MX (1)	MX9203444A (cs)
NL (1)	NL300103I2 (cs)
NO (2)	NO304774B1 (cs)
NZ (1)	NZ243288A (cs)
PL (3)	PL171034B1 (cs)
PT (1)	PT100620B (cs)
RU (1)	RU2137474C1 (cs)
SA (1)	SA92130141B1 (cs)
SG (1)	SG47877A1 (cs)
SI (1)	SI9200125B (cs)
SK (3)	SK280906B6 (cs)
TW (1)	TW214544B (cs)
UA (1)	UA41254C2 (cs)
WO (1)	WO1993000086A1 (cs)
ZA (1)	ZA924658B (cs)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9211277D0 (en)	1992-05-28	1992-07-15	Glaxo Group Inc	Pharmaceutical compositions
GB9226530D0 (en) *	1992-12-21	1993-02-17	Smithkline Beecham Plc	Compounds
US5616603A (en) *	1995-05-26	1997-04-01	Smithkline Beecham Plc	Enantiomers of carbazole derivatives as 5-HT1 -like agonists
GB9226566D0 (en) *	1992-12-21	1993-02-17	Smithkline Beecham Plc	Compounds
US5618948A (en) *	1995-05-26	1997-04-08	Smithkline Beecham P.L.C.	Process for preparing an enantiomer of a carbazole derivative
DE69610793T2 (de) *	1995-06-23	2001-05-03	Eli Lilly And Co., Indianapolis	6-Subsitituierte-1,2,3,4-tetrahydro-9H-Carbazole und 7-substituierte-1OH-Cyclohepta(7,6-B)-Indole
US5917054A (en) *	1995-07-18	1999-06-29	Smithkline Beecham P.L.C.	Process for preparing enantiomers of carbazole derivatives as 5-HT1 -like agonists
US5708187A (en) *	1996-06-27	1998-01-13	Eli Lilly And Company	6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and 7-substituted-10H-cyclohepta 7,6-B!indoles: New 5-HT1F agonists
US5891885A (en) *	1996-10-09	1999-04-06	Algos Pharmaceutical Corporation	Method for treating migraine
GB9723061D0 (en) *	1997-10-31	1998-01-07	Vanguard Medica Ltd	Medicaments
US7189753B1 (en)	1997-11-06	2007-03-13	Cady Roger K	Preemptive prophylaxis of migraine
US6066092A (en) *	1997-11-06	2000-05-23	Cady; Roger K.	Preemptive prophylaxis of migraine device and method
GB9808069D0 (en) *	1998-04-16	1998-06-17	Vanguard Medica Ltd	Novel processes
GB9817911D0 (en) *	1998-08-17	1998-10-14	Vanguard Medica Ltd	New use
US20030198669A1 (en) *	2001-07-05	2003-10-23	R.T. Alamo Ventures I, Llc	Compositions and methods for rapid dissolving formulations of dihydroergotamine and caffeine for the treatment of migraine
US20030017175A1 (en) *	2001-07-05	2003-01-23	R.T. Alamo Ventures I, Inc.	Sublingual administration of dihydroergotamine for the treatment of migraine
US6685951B2 (en)	2001-07-05	2004-02-03	R. T. Alamo Ventures I, Inc.	Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine
US7297711B2 (en)	2002-06-21	2007-11-20	Suven Life Sciences Limited	Arylalkyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
DE60317333T2 (de)	2002-06-21	2008-08-28	Suven Life Sciences Ltd.	Tetracyklische arylsulfonylindole mit affinität zum serotonin rezeptor
JP4782425B2 (ja)	2002-11-28	2011-09-28	スベンライフサイエンシズリミティド	Ｎ−アリールスルホニル−３−アミノアルコキシインドール
WO2004048330A1 (en)	2002-11-28	2004-06-10	Suven Life Sciences Limited	N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them
EA009367B1 (ru)	2002-12-18	2007-12-28	Сувен Лайф Сайенсиз Лимитед	ПРОИЗВОДНЫЕ 5-ТИА-5-ДИОКСО-4b-АЗАИНДЕНО[2,1-a]ИНДЕНА, ОБЛАДАЮЩИЕ АФФИННОСТЬЮ К РЕЦЕПТОРУ СЕРОТОНИНА
KR101411820B1 (ko) *	2006-08-07	2014-06-24	액테리온 파마슈티칼 리미티드	(3-아미노-1,2,3,4-테트라하이드로-9ｈ-카르바졸-9-일)-아세트산 유도체
US8653066B2 (en)	2006-10-09	2014-02-18	Charleston Laboratories, Inc.	Pharmaceutical compositions
PT2425820E (pt)	2007-02-11	2015-08-04	Map Pharmaceuticals Inc	Método de administração terapêutica de dhe para permitir o rápido alívio das enxaquecas ao mesmo tempo que minimiza o perfil de efeitos secundários
US20090069399A1 (en) *	2007-09-12	2009-03-12	Protia, Llc	Deuterium-enriched frovatriptan
US8124126B2 (en)	2008-01-09	2012-02-28	Charleston Laboratories, Inc.	Pharmaceutical compositions
WO2010073253A1 (en) *	2008-12-22	2010-07-01	Natco Pharma Limited	Method for preparing an optically active frovatriptan
EP3311667A1 (en)	2009-07-08	2018-04-25	Charleston Laboratories, Inc.	Pharmaceutical compositions
US9204906B2 (en)	2009-10-22	2015-12-08	Nuvasive, Inc.	Posterior cervical fusion system and techniques
US10098674B2 (en)	2009-10-22	2018-10-16	Nuvasive, Inc.	System and method for posterior cervical fusion
EP2734634B1 (en)	2011-07-22	2019-08-21	The University of Chicago	Igf-1 for use in the treatment of migraine
US9394314B2 (en)	2012-12-21	2016-07-19	Map Pharmaceuticals, Inc.	8′-hydroxy-dihydroergotamine compounds and compositions
EP2816030A1 (en)	2013-06-20	2014-12-24	Duke Chem, S. A.	Process for the preparation of frovatriptan and its enantiomer
GB201312768D0 (en) *	2013-07-17	2013-08-28	Ge Healthcare Ltd	Work-up procedure
WO2017152130A1 (en)	2016-03-04	2017-09-08	Charleston Laboratories, Inc.	Pharmaceutical compositions
EP3766483A1 (en)	2019-07-19	2021-01-20	BioPharma Synergies, S. L.	Orodispersible powder composition comprising a triptan

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3642816A (en) *	1967-08-10	1972-02-15	Sterling Drug Inc	3-acetamido-1 2 3 4-tetrahydrocarbazole
US3959309A (en) *	1968-01-24	1976-05-25	Sterling Drug Inc.	3-Amido-1,2,3,4-tetrahydrocarbazoles
US4062864A (en) *	1968-01-24	1977-12-13	Sterling Drug Inc.	3-Hydroxy carbazole derivatives
US3592824A (en) *	1970-03-12	1971-07-13	Miles Lab	3-substituted amino-1,2,3,4-tetrahydrocarbazoles
US4172834A (en) *	1971-08-16	1979-10-30	Sterling Drug Inc.	3-Amino-tetrahydrocarbazoles
BE787537A (fr) *	1971-08-16	1973-02-14	Sterling Drug Inc	Tetrahydrocarbazoles
US4257952A (en) *	1977-06-06	1981-03-24	Sterling Drug Inc.	3-Amino-tetrahydrocarbazoles
US4254134A (en) *	1978-03-17	1981-03-03	Endo Laboratories, Inc.	Antidepressant 2-amino- and -2-(substituted amino)-cis-hexahydro-carbazoles
EP0115607A1 (de) *	1983-01-04	1984-08-15	MERCK PATENT GmbH	Tetrahydrocarbazolderivate

1991
- 1991-06-26 GB GB919113802A patent/GB9113802D0/en active Pending
1992
- 1992-06-17 UA UA93002251A patent/UA41254C2/uk unknown
- 1992-06-17 EP EP92912379A patent/EP0591280B1/en not_active Expired - Lifetime
- 1992-06-17 PL PL92311304A patent/PL171034B1/pl unknown
- 1992-06-17 CZ CS932861A patent/CZ282083B6/cs not_active IP Right Cessation
- 1992-06-17 SK SK1054-98A patent/SK280906B6/sk not_active IP Right Cessation
- 1992-06-17 US US08/167,846 patent/US5464864A/en not_active Expired - Lifetime
- 1992-06-17 CZ CZ961506A patent/CZ282327B6/cs not_active IP Right Cessation
- 1992-06-17 SK SK1319-93A patent/SK280905B6/sk not_active IP Right Cessation
- 1992-06-17 SK SK1685-98A patent/SK280907B6/sk not_active IP Right Cessation
- 1992-06-17 PL PL92301883A patent/PL169392B1/pl unknown
- 1992-06-17 DK DK92912379T patent/DK0591280T3/da active
- 1992-06-17 BR BR9206237A patent/BR9206237A/pt not_active Application Discontinuation
- 1992-06-17 DE DE69226953T patent/DE69226953T2/de not_active Expired - Lifetime
- 1992-06-17 RU RU93058534A patent/RU2137474C1/ru active Protection Beyond IP Right Term
- 1992-06-17 DE DE2002199042 patent/DE10299042I2/de active Active
- 1992-06-17 PL PL92307118A patent/PL169410B1/pl unknown
- 1992-06-17 HU HU9303731A patent/HU218907B/hu active IP Right Revival
- 1992-06-17 WO PCT/GB1992/001082 patent/WO1993000086A1/en active IP Right Grant
- 1992-06-17 AT AT92912379T patent/ATE170746T1/de active
- 1992-06-17 SG SG1996004938A patent/SG47877A1/en unknown
- 1992-06-17 CA CA002113726A patent/CA2113726C/en not_active Expired - Lifetime
- 1992-06-17 KR KR1019930704055A patent/KR100251571B1/ko not_active IP Right Cessation
- 1992-06-17 CZ CZ961505A patent/CZ282061B6/cs not_active IP Right Cessation
- 1992-06-17 JP JP51108692A patent/JP3261502B2/ja not_active Expired - Lifetime
- 1992-06-24 PT PT100620A patent/PT100620B/pt not_active IP Right Cessation
- 1992-06-24 NZ NZ243288A patent/NZ243288A/en not_active IP Right Cessation
- 1992-06-24 MA MA22853A patent/MA22563A1/fr unknown
- 1992-06-24 ZA ZA924658A patent/ZA924658B/xx unknown
- 1992-06-25 IL IL117105A patent/IL117105A/en not_active IP Right Cessation
- 1992-06-25 CN CN92108831A patent/CN1034072C/zh not_active Expired - Lifetime
- 1992-06-25 TW TW081104991A patent/TW214544B/zh not_active IP Right Cessation
- 1992-06-25 IL IL11710596A patent/IL117105A0/xx unknown
- 1992-06-25 IL IL117104A patent/IL117104A/xx not_active IP Right Cessation
- 1992-06-25 AP APAP/P/1992/000403A patent/AP344A/en active
- 1992-06-25 IL IL102322A patent/IL102322A/xx not_active IP Right Cessation
- 1992-06-26 MX MX9203444A patent/MX9203444A/es unknown
- 1992-06-26 SI SI9200125A patent/SI9200125B/sl unknown
- 1992-07-01 IE IE206292A patent/IE922062A1/en not_active IP Right Cessation
- 1992-10-04 SA SA92130141A patent/SA92130141B1/ar unknown
1993
- 1993-12-23 FI FI935842A patent/FI103967B1/fi not_active IP Right Cessation
- 1993-12-23 NO NO934759A patent/NO304774B1/no not_active IP Right Cessation
1995
- 1995-05-15 US US08/442,719 patent/US5637611A/en not_active Expired - Lifetime
1997
- 1997-05-06 BR BR1100460-6A patent/BR1100460A/pt active IP Right Grant
1998
- 1998-12-28 HK HK98116054A patent/HK1014669A1/xx not_active IP Right Cessation
2002
- 2002-07-24 LU LU90939C patent/LU90939I2/fr unknown
- 2002-10-14 NL NL300103C patent/NL300103I2/nl unknown
2005
- 2005-05-03 NO NO2005011C patent/NO2005011I2/no unknown

Also Published As

Publication number	Publication date
SA92130141B1 (ar)	2005-12-18
NO304774B1 (no)	1999-02-15
ATE170746T1 (de)	1998-09-15
JP3261502B2 (ja)	2002-03-04
NO934800L (no)	1993-12-23
EP0591280B1 (en)	1998-09-09
CZ150696A3 (en)	1997-06-11
AU652842B2 (en)	1994-09-08
MA22563A1 (fr)	1992-12-31
PL169392B1 (pl)	1996-07-31
UA41254C2 (uk)	2001-09-17
FI103967B (fi)	1999-10-29
SK131993A3 (en)	1994-06-08
AP9200403A0 (en)	1992-07-31
BR9206237A (pt)	1995-04-11
BR1100460A (pt)	2000-07-18
NO2005011I1 (no)	2005-05-18
CZ150596A3 (en)	1997-05-14
SI9200125A (en)	1992-12-31
CN1034072C (zh)	1997-02-19
HK1014669A1 (en)	1999-09-30
CA2113726A1 (en)	1993-01-07
DE10299042I2 (de)	2005-02-03
NZ243288A (en)	1994-09-27
WO1993000086A1 (en)	1993-01-07
AU1977592A (en)	1993-01-25
IE922062A1 (en)	1992-12-30
CZ282061B6 (cs)	1997-05-14
CZ282083B6 (cs)	1997-05-14
IL117104A (en)	1997-09-30
HU218907B (hu)	2000-12-28
PL171034B1 (en)	1997-02-28
CZ286193A3 (en)	1994-07-13
NL300103I2 (nl)	2003-02-03
IL117104A0 (en)	1996-06-18
PT100620B (pt)	1999-01-29
DE69226953T2 (de)	1999-05-12
PL169410B1 (pl)	1996-07-31
ZA924658B (en)	1993-12-24
NL300103I1 (nl)	2002-12-02
AP344A (en)	1994-07-05
LU90939I2 (fr)	2002-09-24
FI935842A (fi)	1993-12-23
IL102322A0 (en)	1993-01-14
SK280905B6 (sk)	2000-09-12
IL117105A (en)	1998-01-04
IL117105A0 (en)	1996-06-18
SI9200125B (en)	2001-12-31
RU2137474C1 (ru)	1999-09-20
SK280907B6 (sk)	2000-09-12
PT100620A (pt)	1993-09-30
DE10299042I1 (de)	2003-02-20
JPH06508827A (ja)	1994-10-06
SG47877A1 (en)	1998-04-17
CA2113726C (en)	2008-02-19
GB9113802D0 (en)	1991-08-14
CZ282327B6 (cs)	1997-06-11
IL102322A (en)	1997-09-30
US5637611A (en)	1997-06-10
FI935842A0 (fi)	1993-12-23
HUT68961A (en)	1995-08-28
FI103967B1 (fi)	1999-10-29
MX9203444A (es)	1993-12-01
NO2005011I2 (no)	2008-02-11
DE69226953D1 (de)	1998-10-15
NO934800D0 (no)	1993-12-23
SK280906B6 (sk)	2000-09-12
EP0591280A1 (en)	1994-04-13
KR100251571B1 (ko)	2000-07-01
US5464864A (en)	1995-11-07
TW214544B (cs)	1993-10-11
CN1069726A (zh)	1993-03-10

Publication	Publication Date	Title
DK0591280T3 (da)	1999-02-15	Anvendelse af tetrahydrocarbazolderivater som 5HT1-receptoragonister
DK0516349T3 (da)	1995-11-06	2-hydroxy-2-phenylethylamin-derivater som beta-3-adrenoceptoragonister
KR950700906A (ko)	1995-02-20	5-ht1 작동약으로서의 인돌 유도체(indole derivatives as 5-ht1 agonists)
DK0393936T3 (da)	1995-06-26	3-substituerede 2-oxindolderivater som antiinflammatoriske midler
DK0856001T3 (da)	2002-12-30	Pyrimidinderivater som 5-HT2C-receptor-antagonister
NO943348L (no)	1994-11-09	Kondenserte indolderivater som 5HT4-reseptorantagonister
FI970310A0 (fi)	1997-01-24	4-indolijohdannaiset serotoniinin vaikuttaja- ja vastavaikuttaja-aineina
FI944805A (fi)	1994-10-12	Indolijohdannaisia 5-HT1-kaltaisina agonisteina
FI940574A (fi)	1994-02-08	Bentseenisulfonamidijohdannaiset herbisideinä
DK0696194T3 (da)	2002-10-07	Anvendelse af indolderivater som 5HT1-antagonister
FI962969A (fi)	1996-07-25	Indolijohdannaisia 5-HT1:n agonisteina
FI961628A0 (fi)	1996-04-12	Indolijohdannaisia NMDA-antagonisteina
DK0453915T3 (da)	1994-04-18	Anvendelse af N-alkyl-lactamer som krystallisationsinhibitorer
FI940192A0 (fi)	1994-01-14	2-(4-hydroksipiperidino)-1-alkonolijohdannaisia verettömyyden vastaisina aineina
DK0769293T3 (da)	1999-12-06	Anvendelse af mindst en beta-adrenerg agonist som substans P-antagonist
DK0391171T3 (da)	1993-07-12	Anvendelse af di-styryl-phenyl-triglycolether som krystallisationsinhibitor
FI951798A0 (fi)	1995-04-13	Bentsofuraanijohdannaiset 5-HT1-kaltaisina reseptoriantagonisteina
AR005008A1 (es)	1999-04-07	Compuestos benzotiazolona etanaminas, procedimiento e intermediarios para su preparacion y su uso en la preparacion de medicamentos
FI941136A0 (fi)	1994-03-10	Kamferin piperatsinyyli(sulfonyyli)amidijohdannaiset oksitosiiniantagonisteina
DE69320653D1 (de)	1998-10-01	Tetrahydrocarbazolderivate als 5-ht1-ähnliche agonisten
FI943119A0 (fi)	1994-06-29	Heterosyklisellä renkaalla substituoituja bentsyyliamiinijohdannaisia retrovirusvastaisina yhdisteinä
ES2164168T3 (es)	2002-02-16	Antagonistas de receptores de fibrinogeno que tienen residuos de beta-aminoacido sustituidos y composiciones farmaceuticas que comprenden los mismos.
DE69213961D1 (de)	1996-10-24	Benzolsulfonamid derivate
MX9206075A (es)	1993-04-01	Nuevos compuestos antagonistas del receptor 5-hidroxitriptamina y composiciones farmaceuticas que los contienen
DK0402857T3 (da)	1991-10-09	Anvendelse af 17beta-cyclopropylamino-androsten-derivater